๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Taiyuan
Clinical trial register · China

Clinical Trials in Taiyuan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Taiyuan 15
Narrow the registerReset
Recruitment status
Phase
Site location
Taiyuan15
All 1 locations
Target enrolment
to

Trials with a site in Taiyuan

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
NCT07514052Multiple Myeloma of Bone
Shanxi Bethune Hospital
Observational
127
Taiyuan
2026-01-01
Recruiting
Intraosseous Infusion in Hematologic Critical Patients
NCT07239375Intraosseous Infusions
Shanxi Bethune Hospital
Observational
52
Taiyuan
2025-11-22
Recruiting
Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management
NCT07265037Diabetes Mellitus, Type 2, Integrated Traditional Chinese Medicine and Western Medicine, Telemedicine, Chronic Disease Management
Shanxi Bethune Hospital
Not applicable
10,000
Taiyuan
2025-11-01
Recruiting
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
NCT07497165Relapsed/Refractory Multiple Myeloma (RRMM), Multiple Myeloma
Shanxi Bethune Hospital
Observational
48
Taiyuan
2025-11-01
Recruiting
Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
NCT07204522Febrile Neutropenia
Shanxi Bethune Hospital
Observational
20
Taiyuan
2025-09-22
Recruiting
CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
NCT06850285Lymphoma, B-Cell
Shanxi Bethune Hospital
Not applicable
15
Taiyuan
2025-09-05
Recruiting
Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study
NCT07108530Acute Myeloid Leukemia
Shanxi Bethune Hospital
Phase 2
50
Taiyuan
2025-08-06
Recruiting
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
NCT07059156Acute Lymphoblastic Leukemia, Adult
Shanxi Bethune Hospital
Phase 2/3
50
Taiyuan
2025-06-01
Recruiting
Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT
NCT06909071T2DM Patients With Traumatic Brain Injury
Shanxi Bethune Hospital
Not applicable
40
Taiyuan
2025-04-15
Recruiting
Hybrid Closed-Loop in Diabetes Post-Kidney Transplant: A Randomized Trial
NCT06962410Diabetes Mellitus Patients With Kidney Transplantation
Shanxi Bethune Hospital
Not applicable
30
Taiyuan
2025-04-01
Recruiting
Hybrid Closed-Loop System in LADA Patients: A Randomized Trial
NCT06941675Latent Autoimmune Diabetes in Adults (LADA)
Shanxi Bethune Hospital
Not applicable
50
Taiyuan
2025-04-01
Recruiting
Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study
NCT06650553Aplastic Anemias
Shanxi Bethune Hospital
Not applicable
110
Taiyuan
2024-06-01
Not yet open
JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases
NCT06243159Autoimmune Diseases
Shanxi Bethune Hospital
Phase EARLY_PHASE1
20
Taiyuan
2024-02-08
Recruiting
A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
NCT06783816Acute Lymphocytic Leukemia, Lymphoma,Non-Hodgkin, Relapsed Refractory Multiple Myeloma
Shanxi Bethune Hospital
Not applicable
45
Taiyuan
2023-12-01
Recruiting
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
NCT05726110Relapsed or Refractory Acute Myeloid Leukemia
Shanxi Bethune Hospital
Phase 3
50
Taiyuan
2023-01-29
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/taiyuan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Taiyuan that also match the filters currently applied.

How many clinical trials are recruiting in Taiyuan?

14 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Taiyuan), 15 studies
PhaseStudiesRecruitingShare
Not applicable7746.7%
Observational4426.7%
Phase 2116.7%
Phase 2/3116.7%
Phase 3116.7%
Phase EARLY_PHASE1106.7%

Most active sponsors

Lead sponsors with the most studies (Taiyuan)
Lead sponsorStudiesRecruiting
Shanxi Bethune Hospital1514
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.